The Conditional Marketing Authorisation of Covid-19 Vaccines: A Critical Assessment under EU Law.
Eur J Health Law
; 29(1): 33-52, 2022 03 04.
Article
in English
| MEDLINE | ID: covidwho-1752960
ABSTRACT
The decision of the EU Commission, based on positive advice from the European Medicines Agency, to grant conditional marketing authorisation to Covid-19 vaccines should be qualified as a precautionary measure. Under the established case law of the CJEU, the conditions for the application of this principle are met. Such conditions are the existence of a risk to the environment and public health and uncertainty. Given this qualification as a precautionary measure, whether the Commission had complied with the procedural obligations that surround the implementation of this principle under EU law was assessed. Some shortcomings are identified concerning the risk assessment conducted by the European Medicines Agency and the risk management carried out by the Commission.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Eur J Health Law
Journal subject:
Jurisprudence
/
Public Health
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS